MétaCan
Menu
← Back to cohort
Record W4396779426 · doi:10.4212/cjhp.3543

Antipsychotic Prescribing in Older Adults after In-Hospital Initiation

2024· article· en· W4396779426 on OpenAlexaffvenueabout
Jillian Madey, Samantha Tri, Aleina Haines, Stephanie A. Zimmer, Katelyn Halpape, Zack Dumont

Bibliographic record

VenueThe Canadian Journal of Hospital Pharmacy · 2024
Typearticle
Languageen
FieldMedicine
TopicIntensive Care Unit Cognitive Disorders
Canadian institutionsUniversity of SaskatchewanSaskatchewan HealthSaskatchewan Health Authority
Fundersnot available
KeywordsDeliriumAntipsychoticMedicineDementiaPsychiatryAdverse effectHospital dischargePediatricsIntensive care medicineSchizophrenia (object-oriented programming)Internal medicineDisease

Abstract

fetched live from OpenAlex

Background: In older adults, the use of antipsychotics to treat delirium or the behavioural and psychological symptoms of dementia is potentially inappropriate and may be associated with adverse effects. Antipsychotics newly initiated in hospital may be inadvertently continued after discharge. In the Saskatchewan Health Authority (SHA) – Regina area, the frequency and duration of antipsychotic continuation for older adults after initiation during a hospital stay is unknown. Objectives: To describe potentially inappropriate antipsychotic use in older adults after discharge from hospital, specifically rates of postdischarge antipsychotic therapy after initiation in hospital and continuation up to 180 days after discharge; prescribing regimens used; risk factors associated with continuation; pharmacist involvement; and plans for antipsychotic discontinuation, tapering, and/or follow-up. Methods: This retrospective chart review included inpatients 65 years of age or older who were discharged from medicine units at SHA – Regina area hospitals between September 30, 2021, and June 28, 2022. Outpatient dispensing histories were also gathered. Results: Of the 189 patients included in the analysis, 60 (31.7%) had continuation of antipsychotic therapy at discharge. Of these, 48 (80.0%), 33 (55.0%), and 24 (40.0%) had continuation of antipsychotic therapy at 30, 90, and 180 days after discharge, respectively. Of the patients with continuing antipsychotic therapy, 53 (88.3%) were 75 years of age or older, and 9 (15.0%) had documentation of an outpatient antipsychotic follow-up plan. Conclusions: Postdischarge continuation of antipsychotics was similar to that reported in the literature. Patients continued on antipsychotics after discharge were at a greater than 50% risk of continuation at 90 days and were unlikely to have a follow-up plan. Future quality improvement efforts should include standardized prioritization of medication reviews, documentation of indications, and regular reassessment of therapy. Keywords: antipsychotics, older adults, delirium, dementia, behavioural and psychological symptoms of dementia, prescribing RÉSUMÉ Contexte : Chez les personnes âgées, l’utilisation d’antipsychotiques pour traiter le délire ou les symptômes comportementaux et psychologiques de la démence est potentiellement inappropriée et associée à des effets indésirables. Le traitement antipsychotique initié à l’hôpital pourrait se poursuivre par inadvertance après le congé. Dans la région de Regina de la Saskatchewan Health Authority (SHA), la fréquence et la durée du maintien d’antipsychotiques chez les personnes âgées après l’initiation au cours d’un séjour à l’hôpital sont inconnues. Objectifs : Décrire l’utilisation potentiellement inappropriée d’antipsychotiques chez les personnes âgées après le congé de l’hôpital, en particulier les taux de traitement antipsychotique initié à l’hôpital qui continue après le congé et son maintien jusqu’à 180 jours après le congé; les schémas de prescription utilisés; les facteurs de risque associés au maintien; l’implication du pharmacien; et les plans visant à arrêter, réduire progressivement et/ou à faire le suivi de la prise d’antipsychotiques. Méthodologie : Cet examen rétrospectif des dossiers comprenait des patients hospitalisés âgés d’au moins 65 ans qui étaient sortis des unités de médecine d’hôpitaux de la région de Regina de la SHA entre le 30 septembre 2021 et le 28 juin 2022. Les historiques de délivrance en ambulatoire ont également été recueillis. Résultats : Sur les 189 patients inclus dans l’analyse, 60 (31,7 %) ont continué leur traitement antipsychotique au moment du congé. Parmi eux, 48 (80,0 %), 33 (55,0 %) et 24 (40,0 %) continuaient leur traitement antipsychotique à 30, 90 et 180 jours après leur congé, respectivement. Parmi les patients recevant un traitement antipsychotique continu, 53 (88,3 %) étaient âgés d’au moins 75 ans et 9 (15,0 %) avaient un plan de suivi antipsychotique ambulatoire. Conclusions : Le maintien des antipsychotiques après le congé était similaire à celui rapporté dans la littérature. Les patients qui continuaient à prendre des antipsychotiques après leur congé couraient un risque supérieur à 50 % de continuer à 90 jours et étaient peu susceptibles de disposer d’un plan de suivi. Les futurs efforts d’amélioration de la qualité devraient comprendre une priorisation standardisée des examens des médicaments, la documentation des indications et une réévaluation régulière du traitement. Mots-clés: antipsychotiques, personnes âgées, délire, démence, symptômes comportementaux et psychologiques de la démence, prescription

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.013
Threshold uncertainty score0.026

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.276
Teacher spread0.266 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2024
Admission routes3
Has abstractyes

Explore more

Same venueThe Canadian Journal of Hospital Pharmacy→Same topicIntensive Care Unit Cognitive Disorders→French-language works237,207→